Aadi Bioscience Files 8-K: Material Agreement & Shareholder Vote
Ticker: WHWK · Form: 8-K · Filed: Mar 4, 2025 · CIK: 1422142
| Field | Detail |
|---|---|
| Company | Aadi Bioscience, INC. (WHWK) |
| Form Type | 8-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, shareholder-vote, regulation-fd
Related Tickers: AADI
TL;DR
AADI filed an 8-K for a material agreement and shareholder vote. Big moves ahead.
AI Summary
On February 28, 2025, Aadi Bioscience, Inc. entered into a Material Definitive Agreement. The company also submitted matters to a vote of its security holders and made a Regulation FD Disclosure. The filing includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate actions, including a material definitive agreement and a shareholder vote, which could impact the company's strategic direction and financial future.
Risk Assessment
Risk Level: medium — Material definitive agreements and shareholder votes can introduce significant changes and uncertainties for a company.
Key Players & Entities
- Aadi Bioscience, Inc. (company) — Registrant
- February 28, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-38560 (identifier) — Commission File Number
- 61-1547850 (identifier) — I.R.S. Employer Identification No.
FAQ
What is the nature of the Material Definitive Agreement entered into by Aadi Bioscience, Inc. on February 28, 2025?
The filing indicates the entry into a Material Definitive Agreement, but the specific details of this agreement are not provided in the provided text snippet.
What matters were submitted to a vote of Aadi Bioscience, Inc.'s security holders?
The filing states that matters were submitted to a vote of security holders, but the specific proposals are not detailed in the provided text.
What is the significance of the Regulation FD Disclosure mentioned in the filing?
A Regulation FD Disclosure ensures that material information is broadly disseminated to the public, preventing selective disclosure.
What financial statements and exhibits are included with this 8-K filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific content of these documents is not detailed in the provided text.
When was Aadi Bioscience, Inc. incorporated and in which jurisdiction?
Aadi Bioscience, Inc. was incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 regarding Aadi Bioscience, Inc. (WHWK).